English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Humira
Patient Daily
| Apr 28, 2026
Archo Advocacy CEO Toresco on PBMs: 'PBMs profit from keeping prices high. Patients pay the spread'
Trending
Patient Daily
| Apr 23, 2026
Taxpayers Protection Alliance director says 340B program raises costs for patients and taxpayers
+
Pharmaceuticals
Patient Daily
| Apr 23, 2026
Bristol Myers Squibb spinout Beeline Medicines launches with $300 million and five assets
+
Pharmaceuticals
Patient Daily
| Apr 24, 2026
Washington Post Opinion Editor on 340B drug discounts: 'The program has become a profit-making venture for big businesses'
+
Regulatory
Patient Daily
| Apr 24, 2026
Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’
